ATARA BIOTHERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $279.6M | $106.1M |
| FY2022 | — | $126.6M | $92.9M |
| FY2023 | — | $99.2M | $25.8M |
| FY2024 | — | $-97.3M | $25.0M |
| FY2025 | — | $-38.5M | $8.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $279.6M | $106.1M |
| FY2022 | — | $126.6M | $92.9M |
| FY2023 | — | $99.2M | $25.8M |
| FY2024 | — | $-97.3M | $25.0M |
| FY2025 | — | $-38.5M | $8.5M |